>
Switch to:

Corcept Therapeutics COGS-to-Revenue

: 0.01 (As of Dec. 2020)
View and export this data going back to 2004. Start your Free Trial

Corcept Therapeutics's Cost of Goods Sold for the three months ended in Dec. 2020 was $1.3 Mil. Its Revenue for the three months ended in Dec. 2020 was $85.7 Mil.

Corcept Therapeutics's COGS to Revenue for the three months ended in Dec. 2020 was 0.01.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Corcept Therapeutics's Gross Margin % for the three months ended in Dec. 2020 was 98.54%.


Corcept Therapeutics COGS-to-Revenue Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.

* Premium members only.

Corcept Therapeutics Annual Data
Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
COGS-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.02 0.02 0.02 0.02

Corcept Therapeutics Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
COGS-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.02 0.01 0.01 0.01

Corcept Therapeutics COGS-to-Revenue Calculation

Corcept Therapeutics's COGS to Revenue for the fiscal year that ended in Dec. 2020 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=5.582 / 353.874
=0.02

Corcept Therapeutics's COGS to Revenue for the quarter that ended in Dec. 2020 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=1.254 / 85.735
=0.01

* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.


Corcept Therapeutics  (NAS:CORT) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Corcept Therapeutics's Gross Margin % for the three months ended in Dec. 2020 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 1.254 / 85.735
=98.54 %

* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Corcept Therapeutics COGS-to-Revenue Related Terms


Corcept Therapeutics COGS-to-Revenue Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)